Next-generation sequencing of ENKTL and aggressive NK-cell leukemia (ANKL) has shown recurrent mutations in the JAK/STAT pathway, particularly in STAT3 and STAT5B in both lymphoma entities. The gene discussed is STAT3; the disease is aggressive NK-cell leukemia.